Alkyl-esters of polyacrylic acid as vaccine adjuvants

By Hilgers L.A.T.   Nicolas I.   Lejeune G.   Dewil E.   Strebelle M.   Boon B.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1575-1581

Elsevier

Access to resources Recommend Favorite

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

By Fujihashi K.   Koga T.   van Ginkel F.W.   Hagiwara Y.   McGhee J.R.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2431-2438

Elsevier

Access to resources Recommend Favorite

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

By Barchfeld G.L.   Hessler A.L.   Chen M.   Pizza M.   Rappuoli R.   Van Nest G.A.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 695-704

Elsevier

Access to resources Recommend Favorite

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

By Berstad A.K.H.   Andersen S.R.   Dalseg R.   Dromtorp S.   Holst J.   Namork E.   Wedege E.   Haneberg B.  

Vaccine, Vol. 18, Iss. 18, 2000-03 ,pp. : 1910-1919

Elsevier

Access to resources Recommend Favorite

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses

By Sjolander S.   Drane D.   Davis R.   Beezum L.   Pearse M.   Cox J.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 4072-4080

Elsevier

Access to resources Recommend Favorite